• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $STEX

    Streamex Corp.

    Subscribe to $STEX
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Streamex Corp.

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    See more ratings

    Streamex Corp. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Marciano Anthony Mark bought $20,052 worth of shares (17,745 units at $1.13), increasing direct ownership by 18% to 117,745 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/22/26 4:05:25 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $153,099 worth of shares (147,000 units at $1.04) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/21/26 4:47:07 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Executive Chairman Lekstrom Morgan Lee bought $50,000 worth of shares (20,000 units at $2.50) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/18/26 1:41:34 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Large owner Giustra Frank bought $317,000 worth of shares (100,000 units at $3.17) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/4/26 7:04:10 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Lekstrom Morgan Lee bought $71,910 worth of shares (23,500 units at $3.06) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/3/26 11:32:53 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Lekstrom Morgan Lee bought $9,250 worth of shares (2,500 units at $3.70) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    1/29/26 3:30:48 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Large owner Giustra Frank bought $3,000,000 worth of shares (1,000,000 units at $3.00) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    1/27/26 4:59:24 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Lekstrom Morgan Lee bought $17,160 worth of shares (5,500 units at $3.12) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    1/27/26 2:07:11 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Williams Mitchell Young sold $24,915 worth of shares (23,810 units at $1.05), decreasing direct ownership by 0.78% to 3,013,838 units (SEC Form 4) to satisfy withholding obligation

    4 - Streamex Corp. (0001530766) (Issuer)

    6/2/26 9:54:16 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form 4 filed by Interim Executive Chairman Lekstrom Morgan Lee

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:44:06 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Marciano Anthony Mark bought $20,052 worth of shares (17,745 units at $1.13), increasing direct ownership by 18% to 117,745 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/22/26 4:05:25 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $153,099 worth of shares (147,000 units at $1.04) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/21/26 4:47:07 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Investment Officer Williams Mitchell Young was granted 2,250,000 shares and sold $209,718 worth of shares (263,863 units at $0.79), increasing direct ownership by 189% to 3,037,648 units (SEC Form 4) (for withholding tax)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/4/26 5:01:20 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Plummer Christine Marie

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Lekstrom Morgan Lee

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:05 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Mcphie Karl Henry Michael

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:04 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/28/26 4:05:31 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/27/26 6:05:10 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-Q filed by Streamex Corp.

    10-Q - Streamex Corp. (0001530766) (Filer)

    5/14/26 5:24:55 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/4/26 5:00:33 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    4/10/26 4:24:52 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-K filed by Streamex Corp.

    10-K - Streamex Corp. (0001530766) (Filer)

    3/31/26 5:30:00 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    3/27/26 7:35:16 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    3/20/26 5:03:08 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    3/6/26 4:01:51 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    2/13/26 5:09:54 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset

    WINTER PARK, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the launch of 24/7 secondary liquidity infrastructure for holders to trade tokenized securities, developed in partnership with Orca, a leading automated market maker (AMM) infrastructure provider on the Solana blockchain. Streamex's GLDY, a gold-backed, yield-bearing tokenized security, is the inaugural asset to trade on this infrastructure, in the "GLDY Pool on Orca." This marks a significant milestone for the broader tokenized real-world asset market as a vital piece of

    5/27/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces April 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced the distribution of the second yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from April 1st through April 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Gold on lease is currently earning an annualized lease yield of 3.5%. For the mo

    5/18/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Reports Q1 2026 Financial Results and Announces Business & Quarterly Update Call

    WINTER PARK, Fla., May 14, 2026 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced that it has filed its Q1 2026 financial results and will host an earnings and corporate update presentation on Wednesday, May 20, 2026, at 4:30 p.m. ET. Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said: "Q1 2026 was a transformative quarter for Streamex. We raised over $40 million in equity capital, fully deleveraged our balance sheet, and launched GLDY. We made our first yield distribution to GLDY holders, paying investors in gold to hold gold for the first tim

    5/14/26 6:01:22 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides May 2026 Shareholder Update

    WINTER PARK, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today re-released the following update to shareholders outlining recent operational progress, platform development, and the Company's strategic outlook. Dear Shareholders, The past quarter has been a period of foundational progress. Following our April update, we want to share where the business stands today and how we are thinking about the opportunity ahead. The Opportunity Industry estimates project the market for tokenized real-world assets at roughly $16 trillion by 2030. The shift from lega

    5/11/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. to Present at the 21st Annual Needham Technology, Media, & Consumer Conference

    WINTER PARK, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that Morgan Lekstrom, Co-Founder and Executive Chairman, and Christine Plummer, Chief Financial Officer, will present at the 21st Annual Needham Technology, Media, & Consumer Conference in New York City. With the Streamex platform now live, revenue generation underway, and additional products in development, the Company is entering the next phase of its growth strategy. Management will outline how Streamex is focused on growing GLDY – a yield-bearing gold-backed to

    5/7/26 9:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces First Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the distribution of the first yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from launch to March 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's gold leasing program, with proceeds distributed to GLDY holders in the form of additional GLDY tokens on a monthly basis. Gold on lease is currently earning an annualized lease yield of 3.5%. For the month of M

    4/28/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

    WINTER PARK, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced webcast details for its earnings and corporate update presentation to be held on Wednesday, April 8, 2026, at 4:30 p.m. EDT. During the webcast, management will provide a recap of the past year, updates on the 2025 financial results, GLDY launch, traction, institutional interest and adoption, continued product development, and the long-term roadmap for 2026 and beyond. A replay of the webcast will be archived on the Company's investor relations website. Details

    4/6/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Highlights Year of Progress, Files Annual Report & Announces Earnings and Corporate Update Presentation

    WINTER PARK, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that it has filed its Annual Report Form 10-K and will host an earnings and corporate update presentation on April 8, 2026. The Company also released a 2025 year-in-review and 2026 subsequent events update highlighting a transformative year of execution and platform development. Key Highlights from the Past Year Strengthened Board and leadership with several key appointments including Mitch Williams, Kevin Gopaul, Shawn Matthews, Anthony Marciano, Christine Plum

    4/1/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Financials

    Live finance-specific insights

    View All

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces April 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced the distribution of the second yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from April 1st through April 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Gold on lease is currently earning an annualized lease yield of 3.5%. For the mo

    5/18/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Reports Q1 2026 Financial Results and Announces Business & Quarterly Update Call

    WINTER PARK, Fla., May 14, 2026 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced that it has filed its Q1 2026 financial results and will host an earnings and corporate update presentation on Wednesday, May 20, 2026, at 4:30 p.m. ET. Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said: "Q1 2026 was a transformative quarter for Streamex. We raised over $40 million in equity capital, fully deleveraged our balance sheet, and launched GLDY. We made our first yield distribution to GLDY holders, paying investors in gold to hold gold for the first tim

    5/14/26 6:01:22 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides May 2026 Shareholder Update

    WINTER PARK, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today re-released the following update to shareholders outlining recent operational progress, platform development, and the Company's strategic outlook. Dear Shareholders, The past quarter has been a period of foundational progress. Following our April update, we want to share where the business stands today and how we are thinking about the opportunity ahead. The Opportunity Industry estimates project the market for tokenized real-world assets at roughly $16 trillion by 2030. The shift from lega

    5/11/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces First Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the distribution of the first yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from launch to March 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's gold leasing program, with proceeds distributed to GLDY holders in the form of additional GLDY tokens on a monthly basis. Gold on lease is currently earning an annualized lease yield of 3.5%. For the month of M

    4/28/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leading Institutional Investment Firm

    LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and real-world asset infrastructure, today announced that it has acquired a 9.9% equity interest in Empress Royalty Corp. ("Empress") (TSXV:EMPR) through a strategic share purchase from Terra Capital Natural Resources Fund Pty Ltd. ("Terra Capital"), a prominent institutional investor. Under the executed Share Purchase Agreement, Streamex acquired 12,671,297 common shares of Empress in exchange for 2,443,750 restricted common shares of Streamex at a US$5.00 STEX share price, representing a premium to the current market price of STEX and an

    12/11/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion

    The launch of Streamex's $100 million USD GLDY pre-sale marks a historic opportunity for gold investors. Investing in gold is no longer just a static store of value, Streamex, through GLDY has created a yield-generating, institutional grade asset designed to offer both spot gold exposure and yield paid in additional ounces of physical gold bullion.  Key Highlights Gold Price Exposure and Gold-Denominated Distributions: GLDY is designed to combine audited physical bullion holdings with yield from institutionally managed gold leases sourced through Monetary Metals. GLDY seeks to provide exposure to the price of gold while targeting periodic distributions paid in additional ounces of gold.Rev

    11/10/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Appoints Morgan Lekstrom as Executive Chairman, and Announces Completed Repayment of Convertible Debenture and Cancellation of SEPA

    WINTER PARK, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that its Co-Founder and Chairman, Morgan Lekstrom, has been named Executive Chairman and will join the executive leadership team. The Company has also announced that the previously entered into Secured Convertible Debentures with YA II PN, LTD., a Cayman Islands exempt limited company ("Yorkville" or "Holder") have been fully repaid and the Standby Equity Purchase Agreement (the "SEPA") previously entered into with Yorkville has been cancelled. "I am honoured and excited to step int

    2/9/26 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Appoints Anthony Marciano, Clinical Professor of Finance at NYU Stern to Board of Directors

    WINTER PARK, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced the appointment of Anthony Marciano, Clinical Professor of Finance at NYU Stern School of Business, to its Board of Directors. In this role, Marciano will bring deep expertise in corporate finance, mergers and acquisitions, and financial markets to strengthen Streamex's governance and strategic capital markets initiatives. He is joining as an independent director. "Anthony is an outstanding addition to our Board. His deep-rooted expertise in institutional finance, combined with a stro

    2/4/26 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Joins Solana Policy Institute in the Project Open Coalition to Advance Regulated On-Chain Trading of Real-World Assets, Including GLDY

    LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization of real-world assets, today announced it has joined Project Open, a landmark initiative working to establish a regulated framework for the issuance and trading of securities on public blockchains. The effort aims to unlock billions in traditional asset value through 24/7 trading, instant settlement, lower costs, and enhanced transparency for all real-world assets, while keeping the United States competitive in financial innovation. Streamex joins Solana Policy Institute united to drive the next era of compliant digital market infrastructur

    12/10/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Appointment of Kevin Gopaul, Global Financial Executive and ETF Pioneer to Its Board of Directors

    LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced the appointment of Kevin Gopaul, global financial executive and pioneering leader in the exchange-traded fund (ETF) industry, to its Board of Directors, effective immediately. Kevin brings more than 25 years of global asset management and capital markets experience, including senior leadership roles as Global Head of ETFs, Chief Investment Officer, and Canadian CEO at BMO Global Asset Management, where he helped architect and scale the firm's $100 billion ETF franchise. He currently serves

    11/18/25 8:09:24 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care